WAM
PFE icon

Werlinich Asset Management’s Pfizer PFE Stock Holding History

Werlinich Asset Management’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$2.64M Buy
92,600
+400
+0.4% +$10.6K 1.02% 30
2026
Q2 		$2.22M Hold
92,200
– – 0.85% 30
2026
Q1 		$2.59M Buy
92,200
+1,100
+1% +$29.3K 1.26% 28
2025
Q4 		$2.28M Sell
91,100
-1,700
-2% -$42.9K 1.12% 27
2025
Q3 		$2.36M Sell
92,800
-1,500
-2% -$37K 1.17% 25
2025
Q2 		$2.29M Sell
94,300
-4,135
-4% -$96.4K 1.25% 22
2025
Q1 		$2.49M Buy
98,435
+5,700
+6% +$149K 1.58% 21
2024
Q4 		$2.45M Buy
92,735
+2,350
+3% +$63.7K 1.43% 23
2024
Q3 		$2.62M Buy
90,385
+225
+0.2% +$6.56K 1.52% 20
2024
Q2 		$2.51M Buy
90,160
+1,350
+2% +$37.2K 1.56% 21
2024
Q1 		$2.47M Buy
88,810
+9,063
+11% +$251K 1.61% 20
2023
Q4 		$2.28M Buy
79,747
+2,197
+3% +$66.4K 1.73% 18
2023
Q3 		$2.57M Sell
77,550
-1,150
-1% -$40.7K 2.12% 16
2023
Q2 		$2.89M Buy
78,700
+1,900
+2% +$74K 2.32% 14
2023
Q1 		$3.13M Buy
76,800
+290
+0.4% +$12.5K 2.75% 11
2022
Q4 		$3.92M Buy
76,510
+365
+0.5% +$17.5K 3.63% 8
2022
Q3 		$3.33M Sell
76,145
-300
-0.4% -$14.6K 3.41% 10
2022
Q2 		$4.01M Sell
76,445
-1,000
-1% -$51K 3.75% 7
2022
Q1 		$4.01M Buy
77,445
+110
+0.1% +$5.71K 3.05% 10
2021
Q4 		$4.57M Hold
77,335
– – 3.33% 9
2021
Q3 		$3.33M Sell
77,335
-10,240
-12% -$454K 2.69% 10
2021
Q2 		$3.43M Hold
87,575
– – 2.77% 11
2021
Q1 		$3.17M Buy
+87,575
New +$3.11M 2.79% 9

Other funds holding PFE

BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $348B AUM 26.9% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $296B AUM 23.14% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $142B AUM 43.93% 1-Year Est. Return
Amundi
Amundi Paris, France $496B AUM 35.36% 1-Year Est. Return

Werlinich Asset Management's PFE Position: Q3 2026 in Review

Werlinich Asset Management increased its Pfizer (PFE) stake by 0.43% in Q3 2026, buying an estimated $10.6K and bringing the position to 92,600 shares worth $2.64M. The position accounts for 1.02% of the portfolio, ranked #30.

Werlinich Asset Management first reported a position in PFE in Q1 2021 and has held it in 23 quarters since. The position peaked at $4.57M in Q4 2021. 2,556 funds tracked by Wall St. Rank hold PFE as of Q3 2026.

  • Werlinich Asset Management held 92,600 shares of Pfizer worth $2.64M as of Q3 2026.
  • Werlinich Asset Management bought 400 Pfizer shares in Q3 2026, an estimated $10.6K.
  • Pfizer made up 1.02% of Werlinich Asset Management's portfolio in Q3 2026, its #30 holding.
  • Werlinich Asset Management first reported a position in Pfizer in Q1 2021 and has held it in 23 quarters since.
  • Werlinich Asset Management's Pfizer position peaked at $4.57M in Q4 2021.
  • 2,556 funds tracked by Wall St. Rank held Pfizer as of Q3 2026.

Based on Werlinich Asset Management's 13F filing for Q3 2026, filed 9 Oct 2026.